A scoping review of preoperative weight loss interventions on postoperative outcomes for patients with gastrointestinal cancer

Yangyue Zhang,Natalia Tomborelli Bellafronte,Gezal Najafitirehshabankareh,Michelle Huamani Jimenez,Emily Jaeger-McEnroe,Hughes Plourde,Mary Hendrickson,Chelsia Gillis

DOI: https://doi.org/10.1016/j.ejso.2024.108743

IF: 4.037

2024-10-14

European Journal of Surgical Oncology

Abstract:Background Obesity is associated with increased risk of surgical complications in some settings. Objective As a precursor to a systematic review, we conducted a scoping review of intentional preoperative weight loss to describe these interventions, their feasibility and effectiveness for patients with gastrointestinal cancer. Methods In April 2024, Ovid MEDLINE, EMBASE, CINAHL, and Google Scholar were searched for primary studies of intentional weight loss before elective gastrointestinal cancer surgery. Extracted data encompassed recruitment and attrition, intervention types, adherence, anthropometric and body composition changes, and surgical outcomes. Study quality was assessed using the Risk of Bias In Non-randomized Studies of Interventions tool. Results The search produced 7 articles (4 non-randomized clinical trials), which were all conducted in Japan, and involved 258 participants with a baseline BMI ≥ 25 kg/m 2 . Weight loss interventions included dietary modification (n = 3), exercise (n = 1), and combined (n = 3). None of the studies reported rates of recruitment, 2 adherence (97-100%), and 4 reported attrition rates (0-18%). All trials reported weight reductions of –1.3 to –6 kg and 4.5 to 6.9% (n = 7), compared to baseline. Three of four non-randomized trials observed a reduction in postoperative complications, as compared to control; yet all trials were at critical risk of bias. Conclusion Strong conclusions could not be made due to the limited reporting and critical risk of bias; further systematic review is not recommended at this time. To establish more robust evidence, there is a clear need for high-quality trials.

oncology,surgery